×

Our award-winning reporting has moved

Context provides news and analysis on three of the world’s most critical issues:

climate change, the impact of technology on society, and inclusive economies.

BROWSE THE ARCHIVE VISIT CONTEXT

BRIEF-India's Drug Regulator CDSCO Upgraded Covaxin, Covishield To Normal New Drug Permission In Adult Population With Certain Conditions - Health Minister

by Reuters
Thursday, 27 January 2022 10:16 GMT
About our Humanitarian Crises coverage
From major disaster, conflicts and under-reported stories, we shine a light on the world’s hotspots
Trending

(Corrects typo in headline)

Jan 27 (Reuters) -

* CDSCO HAS NOW UPGRADED THE PERMISSION FOR COVAXIN & COVISHIELD FROM RESTRICTED USE IN EMERGENCY SITUATIONS TO NORMAL NEW DRUG PERMISSION IN THE ADULT POPULATION WITH CERTAIN CONDITIONS. - INDIA'S HEALTH MINISTER

Our Standards: The Thomson Reuters Trust Principles.

Themes
EXPLORE MORE Humanitarian Crises NEWS
-->